These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 2693046)

  • 1. Urapidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.
    Langtry HD; Mammen GJ; Sorkin EM
    Drugs; 1989 Dec; 38(6):900-40. PubMed ID: 2693046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urapidil. A reappraisal of its use in the management of hypertension.
    Dooley M; Goa KL
    Drugs; 1998 Nov; 56(5):929-55. PubMed ID: 9829161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension.
    Titmarsh S; Monk JP
    Drugs; 1987 May; 33(5):461-77. PubMed ID: 2885169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hypertension in patients with pre-eclampsia: a prospective parallel-group study comparing dihydralazine with urapidil.
    Wacker J; Werner P; Walter-Sack I; Bastert G
    Nephrol Dial Transplant; 1998 Feb; 13(2):318-25. PubMed ID: 9509441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind comparison of urapidil and prazosin in the treatment of patients with essential hypertension.
    Kaneko Y
    Drugs; 1988; 35 Suppl 6():156-63. PubMed ID: 3042355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of urapidil in the treatment of acute hypertension].
    Lehot JJ; Bonnefoy E; Dalmas JP; Filley S; Bastien O; George M
    Cah Anesthesiol; 1995; 43(1):67-76. PubMed ID: 7671060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urapidil, a dual-acting antihypertensive agent: Current usage considerations.
    Buch J
    Adv Ther; 2010 Jul; 27(7):426-43. PubMed ID: 20652659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemodynamic effects of urapidil in men].
    M'Buyamba-Kabangu JR; Bielen E; Staessen J; Fagard R; Lijnen P; Van Hoof R; Amery A
    Presse Med; 1990 Sep; 19(30):1407-11. PubMed ID: 2146624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urapidil-induced hemodynamic changes in humans.
    Bielen E; Fagard R; Staessen J; Lijnen P; Van Hoof R; Amery A
    Am J Cardiol; 1989 Aug; 64(7):16D-21D. PubMed ID: 2667309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antihypertensive effect of urapidil in mild to moderate arterial hypertension. Randomized, double-blind versus placebo study].
    Amodeo C; Barros LM; Batlouni M; Sousa JE
    Arq Bras Cardiol; 1993 Aug; 61(2):127-30. PubMed ID: 8297222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of once-daily urapidil treatment in mild or moderate essential hypertension assessed by ambulatory 24-hour blood pressure monitoring.
    Trimarco B; Rosiello G; Feldhaus P; Steinijans VW; Vecchione F; Cuocolo A; Lembo G; Volpe M
    Drugs; 1988; 35 Suppl 6():173-81. PubMed ID: 3402355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the antihypertensive efficacy of urapidil in the treatment of hypertension emergencies].
    Błaszyk K; Grajek S; Skorupski W; Popiel M; Wnuk H; Mitkowski P; Cieśliński A
    Pol Arch Med Wewn; 1995 Dec; 94(6):512-7. PubMed ID: 8618814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic haemodynamic and humoral changes during urapidil treatment in hypertensive patients.
    Leonetti G; Terzoli L; Zanchetti A
    J Hypertens Suppl; 1988 Dec; 6(2):S25-9. PubMed ID: 2906697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of the hypertensive crisis with urapidil. Various effects on patients with or without coronary disease].
    Zähringer J; Klepzig M; Greif J; Ludwig B; Strauer B
    Fortschr Med; 1984 Jun; 102(22):624-8. PubMed ID: 6469170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects and interaction with adrenoceptors of urapidil.
    van Zwieten PA; de Jonge A; Wilffert B; Timmermans PB; Beckeringh JJ; Thoolen MJ
    Arch Int Pharmacodyn Ther; 1985 Aug; 276(2):180-201. PubMed ID: 4051641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of mild hypertension with urapidil or captopril.
    Rosenthal J; Schäfer N; Haerlin R; Wurst W; Solleder P
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):233S-236S. PubMed ID: 3046630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of clinical trials with urapidil.
    Schook CE; Radtke H; Wurst W; Thieme G
    Am J Cardiol; 1989 Aug; 64(7):30D-37D. PubMed ID: 2667312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic effects of urapidil in arterial hypertension and congestive heart failure.
    Messerli FH
    Drugs; 1988; 35 Suppl 6():70-3. PubMed ID: 3042361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of urapidil and sodium nitroprusside in the treatment of hypertensive emergencies.
    Hirschl MM; Binder M; Bur A; Herkner H; Müllner M; Woisetschläger C; Laggner AN
    Intensive Care Med; 1997 Aug; 23(8):885-8. PubMed ID: 9310807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.